Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
Provided By GlobeNewswire
Last update: Oct 2, 2023
Refinancing of Current $400M Debt at Lower Cost and Improved Amortization Schedule
Blackstone to also Purchase $30M of Amicus Common Stock
Read more at globenewswire.com
